These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 34939674)
1. The multifaceted roles of mass spectrometric analysis in nucleic acids drug discovery and development. Kenderdine T; Fabris D Mass Spectrom Rev; 2023; 42(4):1332-1357. PubMed ID: 34939674 [TBL] [Abstract][Full Text] [Related]
2. A role for the MS analysis of nucleic acids in the post-genomics age. Fabris D J Am Soc Mass Spectrom; 2010 Jan; 21(1):1-13. PubMed ID: 19897384 [TBL] [Abstract][Full Text] [Related]
4. Analysis of nucleic acids by FTICR MS. Hofstadler SA; Sannes-Lowery KA; Hannis JC Mass Spectrom Rev; 2005; 24(2):265-85. PubMed ID: 15389854 [TBL] [Abstract][Full Text] [Related]
5. Mass Spectrometry of Nucleic Acid Noncovalent Complexes. Largy E; König A; Ghosh A; Ghosh D; Benabou S; Rosu F; Gabelica V Chem Rev; 2022 Apr; 122(8):7720-7839. PubMed ID: 34587741 [TBL] [Abstract][Full Text] [Related]
6. Analysis of nucleic acids by on-line liquid chromatography-mass spectrometry. Huber CG; Oberacher H Mass Spectrom Rev; 2001; 20(5):310-43. PubMed ID: 11948655 [TBL] [Abstract][Full Text] [Related]
7. Native Mass Spectrometry and Nucleic Acid G-Quadruplex Biophysics: Advancing Hand in Hand. Gabelica V Acc Chem Res; 2021 Oct; 54(19):3691-3699. PubMed ID: 34546031 [TBL] [Abstract][Full Text] [Related]
8. Advances in surface plasmon resonance biomolecular interaction analysis mass spectrometry (BIA/MS). Nelson RW; Krone JR J Mol Recognit; 1999; 12(2):77-93. PubMed ID: 10398399 [TBL] [Abstract][Full Text] [Related]
9. Recent developments in the characterization of nucleic acids by liquid chromatography, capillary electrophoresis, ion mobility, and mass spectrometry (2010-2020). Santos IC; Brodbelt JS J Sep Sci; 2021 Jan; 44(1):340-372. PubMed ID: 32974962 [TBL] [Abstract][Full Text] [Related]
10. Lipid-Nucleic Acid Complexes: Physicochemical Aspects and Prospects for Cancer Treatment. Gaspar R; Coelho F; Silva BFB Molecules; 2020 Oct; 25(21):. PubMed ID: 33126767 [TBL] [Abstract][Full Text] [Related]
11. Intermolecular interactions in biomolecular systems examined by mass spectrometry. Wyttenbach T; Bowers MT Annu Rev Phys Chem; 2007; 58():511-33. PubMed ID: 17129173 [TBL] [Abstract][Full Text] [Related]
12. Application of different modes of thin-layer chromatography and mass spectrometry for the separation and detection of large and small biomolecules. Tuzimski T J Chromatogr A; 2011 Dec; 1218(49):8799-812. PubMed ID: 22055526 [TBL] [Abstract][Full Text] [Related]
13. Contributions of mass spectrometry in the study of nucleic acid-binding proteins and of nucleic acid-protein interactions. Rusconi F; Guillonneau F; Praseuth D Mass Spectrom Rev; 2002; 21(5):305-48. PubMed ID: 12645088 [TBL] [Abstract][Full Text] [Related]
14. Frontiers of mass spectrometry in nucleic acids analysis. Oberacher H Eur J Mass Spectrom (Chichester); 2010; 16(3):351-65. PubMed ID: 20530841 [TBL] [Abstract][Full Text] [Related]
15. Analysis of protein-nucleic acid interactions by photochemical cross-linking and mass spectrometry. Steen H; Jensen ON Mass Spectrom Rev; 2002; 21(3):163-82. PubMed ID: 12476441 [TBL] [Abstract][Full Text] [Related]
16. Nucleic acids in protein samples interfere with phosphopeptide identification by immobilized-metal-ion affinity chromatography and mass spectrometry. Li Y; Luo Y; Wu S; Gao Y; Liu Y; Zheng D Mol Biotechnol; 2009 Sep; 43(1):59-66. PubMed ID: 19412670 [TBL] [Abstract][Full Text] [Related]
17. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences. Becker JS; Jakubowski N Chem Soc Rev; 2009 Jul; 38(7):1969-83. PubMed ID: 19551177 [TBL] [Abstract][Full Text] [Related]
18. Protein-nucleic acid interactions and the expanding role of mass spectrometry. Hanson CL; Robinson CV J Biol Chem; 2004 Jun; 279(24):24907-10. PubMed ID: 15056667 [TBL] [Abstract][Full Text] [Related]
19. Importance of molecular computer modeling in anticancer drug development. Geromichalos GD J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268 [TBL] [Abstract][Full Text] [Related]